tiprankstipranks
Trending News
More News >
Ilika PLC (GB:IKA)
LSE:IKA
Advertisement

Ilika plc (IKA) AI Stock Analysis

Compare
80 Followers

Top Page

GB:IKA

Ilika plc

(LSE:IKA)

Rating:38Underperform
Price Target:
33.00p
▼(-10.81% Downside)
Ilika plc's overall stock score is primarily impacted by its poor financial performance, characterized by declining revenues and negative profitability. Technical analysis indicates bearish momentum, further weighing down the score. The negative P/E ratio and lack of dividend yield reflect valuation challenges. These factors collectively result in a low overall stock score, highlighting significant risks and challenges facing the company.

Ilika plc (IKA) vs. iShares MSCI United Kingdom ETF (EWC)

Ilika plc Business Overview & Revenue Model

Company DescriptionIlika plc (IKA) is a UK-based advanced materials company specializing in the development of solid-state battery technology and materials for use in various sectors, including electric vehicles, consumer electronics, and renewable energy. The company's core products include high-performance solid-state batteries and materials used in energy storage applications, positioning Ilika as a key player in the growing market for sustainable energy solutions.
How the Company Makes MoneyIlika plc generates revenue primarily through the commercialization of its solid-state battery technology and materials. The company monetizes its innovations through strategic partnerships with automotive and electronics manufacturers, licensing agreements, and the sale of prototype units. Additionally, Ilika engages in research and development contracts, which provide funding and facilitate collaborations aimed at advancing battery technology. The increasing demand for efficient and safe energy storage solutions, especially in the electric vehicle market, significantly contributes to Ilika's revenue potential.

Ilika plc Earnings Call Summary

Earnings Call Date:Jul 17, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Jan 27, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted significant advancements in both Stereax and Goliath battery developments, successful partnerships, and robust patent protection. However, these positives were tempered by financial challenges, including decreased turnover and cash balance, as well as delays in full production and reliance on future grant funding. Overall, the sentiment is cautiously optimistic with balanced prospects.
Q2-2025 Updates
Positive Updates
Successful Commissioning with Cirtec
Ilika completed the commissioning of equipment at Cirtec Medical's site, marking an important step towards Stereax battery production and future revenue streams.
Progress in Goliath Battery Development
The company achieved a 10 amp-hour capacity in its Goliath batteries, representing a fivefold increase from previous prototypes, indicating significant progress in development.
Strong Patent Portfolio
Ilika has secured 62 patents in important jurisdictions worldwide, providing robust protection for their solid-state battery technology.
Strategic Partnerships and Market Interest
Engagement with 21 OEMs and Tier 1 companies for automotive and consumer electronics applications shows strong market interest in Ilika's technology.
Balanced Financial Management
Despite a slight decrease in turnover to £1 million, Ilika maintained its EBITDA loss at £1.9 million, demonstrating effective cost management.
Negative Updates
Turnover Decline
Turnover decreased to £1 million from previous periods, largely due to the winding down of grant funding.
Cash Balance Decline
Ilika's cash balance decreased from £13.2 million to £10.1 million, though this was partially offset by a small raise in May.
Challenges in Securing Grant Funding
There has been a hiatus in available grant funding, impacting financial projections and cash flow management.
Delay in Full Production
Full production for Stereax and Goliath batteries is not expected immediately, with timelines extending into the next 18-24 months.
Company Guidance
In the investor presentation call, Ilika plc provided guidance on its financial and operational progress, particularly focusing on their Stereax and Goliath product lines. The company highlighted its strong patent portfolio of 62 patents and emphasized its business model, which involves licensing its IP to Tier 1 manufacturing partners and OEMs. This model allows Ilika to maintain a low working capital requirement and expedite time to market while minimizing manufacturing risk. Ilika announced that its Stereax batteries, designed for medical devices and industrial IoT applications, have completed commissioning at Cirtec's facility, with production and revenue expected to commence in 2025. The call also covered the company's progress with Goliath batteries, targeting the automotive market, and detailed their safety benefits and potential to reduce EV costs. Ilika's financials showed a turnover of £1,000,000, primarily from grant funding, and an EBITDA loss of £1.9 million, consistent with the previous year. The company maintains a cash balance of £10.1 million and continues to seek grant funding and strategic partnerships to support its growth.

Ilika plc Financial Statement Overview

Summary
Ilika plc is facing significant financial challenges, with declining revenues and negative profitability across key metrics. The balance sheet shows low leverage, which is a positive sign, but the negative return on equity highlights profitability issues. Cash flow remains a concern, although there is some improvement in free cash flow. Overall, the company needs to address its operational inefficiencies and improve its revenue generation to enhance financial health.
Income Statement
20
Very Negative
Ilika plc has experienced significant revenue decline with a negative growth rate of -95.77% in the latest year. The company is facing severe profitability challenges, evidenced by negative gross profit, net profit, EBIT, and EBITDA margins. These metrics indicate substantial operational inefficiencies and a lack of profitability.
Balance Sheet
40
Negative
The balance sheet shows a low debt-to-equity ratio of 0.027, indicating minimal leverage, which is a positive aspect. However, the return on equity is negative, reflecting the company's inability to generate profits from shareholders' equity. The equity ratio is relatively stable, suggesting a moderate level of financial stability.
Cash Flow
30
Negative
Cash flow analysis reveals a negative operating cash flow and free cash flow, though there is a positive free cash flow growth rate of 27.83%. The operating cash flow to net income ratio is negative, indicating cash flow challenges. The free cash flow to net income ratio is above 1, suggesting some efficiency in converting net income to free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue982.90K73.50K20.10K33.85K30.88K230.45K
Gross Profit-453.90K-452.70K-1.06M-1.97M-1.49M-1.06M
EBITDA-5.62M-5.38M-4.00M-7.30M-6.81M-2.68M
Net Income-5.90M-5.90M-4.81M-7.30M-7.13M-3.53M
Balance Sheet
Total Assets19.45M19.45M22.83M26.91M33.93M16.53M
Cash, Cash Equivalents and Short-Term Investments7.98M7.98M11.95M15.87M23.45M9.82M
Total Debt470.70K470.70K625.30K618.48K847.60K827.72K
Total Liabilities2.27M2.27M2.47M2.14M2.50M2.34M
Stockholders Equity17.18M17.18M20.36M24.77M31.44M14.19M
Cash Flow
Free Cash Flow-5.09M-6.28M-4.13M-7.45M-10.08M-4.95M
Operating Cash Flow-4.02M-4.18M-2.46M-6.05M-5.64M-2.13M
Investing Cash Flow2.07M2.47M-5.06M-1.40M-4.44M-2.83M
Financing Cash Flow1.93M1.93M-316.70K-75.78K23.71M-32.94K

Ilika plc Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price37.00
Price Trends
50DMA
41.16
Negative
100DMA
38.46
Negative
200DMA
34.13
Positive
Market Momentum
MACD
-1.30
Positive
RSI
41.15
Neutral
STOCH
23.90
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IKA, the sentiment is Neutral. The current price of 37 is below the 20-day moving average (MA) of 39.27, below the 50-day MA of 41.16, and above the 200-day MA of 34.13, indicating a neutral trend. The MACD of -1.30 indicates Positive momentum. The RSI at 41.15 is Neutral, neither overbought nor oversold. The STOCH value of 23.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:IKA.

Ilika plc Risk Analysis

Ilika plc disclosed 6 risk factors in its most recent earnings report. Ilika plc reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Ilika plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
$10.75B15.697.62%2.01%2.75%-15.14%
58
Neutral
£199.44M-16.93%132.44%47.77%
54
Neutral
£7.00M7.61-1.39%1.74%-10.88%-122.05%
51
Neutral
£92.83M-21.17%-3.32%9.83%
40
Underperform
£103.65M-86.37%732.03%12.60%
38
Underperform
£66.90M-31.45%265.67%-16.50%
£35.37M-58.83%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:IKA
Ilika plc
37.00
11.50
45.10%
GB:AFC
AFC Energy
9.16
-3.14
-25.53%
GB:CWR
Ceres Power Holdings
102.90
-82.40
-44.47%
GB:DIA
Dialight
232.00
7.00
3.11%
GB:LPA
LPA Group plc
53.00
-6.50
-10.92%
GB:GELN
Gelion PLC
20.00
-2.50
-11.11%

Ilika plc Corporate Events

Business Operations and StrategyRegulatory Filings and Compliance
Ilika plc Announces Change in Voting Rights Structure
Neutral
Jun 3, 2025

Ilika plc, a UK-based company, has announced a change in its voting rights structure due to an acquisition or disposal of voting rights by Octopus Investments Limited. The notification reveals that Octopus Investments Limited now holds 4.12% of the voting rights in Ilika plc, an increase from a previous position of 2.86%. This change in voting rights could potentially impact the company’s governance and decision-making processes, reflecting a significant shift in shareholder influence.

The most recent analyst rating on (GB:IKA) stock is a Buy with a £0.95 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.

Private Placements and Financing
Ilika plc’s Oversubscribed Retail Offer Raises £4.2 Million
Positive
May 28, 2025

Ilika plc announced that its recent Retail Offer was significantly oversubscribed, leading the company to increase the scale of the offer to raise £0.9 million through the issuance of 2,727,273 Retail Offer Shares at 33 pence per share. The total fundraising effort, including Placing Shares and Director Subscription Shares, resulted in approximately £4.2 million in gross proceeds, which will be used to further advance the company’s product lines. This successful fundraising effort reflects strong investor confidence and positions Ilika to strengthen its market presence.

The most recent analyst rating on (GB:IKA) stock is a Buy with a £97.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.

Product-Related AnnouncementsPrivate Placements and FinancingBusiness Operations and Strategy
Ilika plc Launches Retail Offer to Raise £0.5 Million for Technology Advancement
Positive
May 22, 2025

Ilika plc has announced a retail offer to raise up to £0.5 million through the issuance of new ordinary shares, as part of a broader capital raising effort that includes a £3.3 million placement and directors’ subscription. The funds raised will be used to advance the commercial launch of its Stereax technology and further develop its Goliath technology, positioning the company for future commercial licensing agreements.

The most recent analyst rating on (GB:IKA) stock is a Buy with a £97.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.

Private Placements and FinancingBusiness Operations and Strategy
Ilika plc Raises £3.3 Million to Boost Battery Technology Commercialization
Positive
May 22, 2025

Ilika plc has successfully raised approximately £3.3 million through a placing and director subscription, exceeding its initial target due to increased demand. The funds will be used to advance the commercial launch of its Stereax and Goliath battery technologies, enhancing its market position and potential for securing commercial licensing agreements. This capital raising reflects strong investor confidence in Ilika’s strategic direction and its commitment to maximizing shareholder returns while minimizing dilution.

The most recent analyst rating on (GB:IKA) stock is a Buy with a £97.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.

Private Placements and FinancingBusiness Operations and Strategy
Ilika plc Announces £3.5 Million Capital Raising to Boost Battery Technology
Positive
May 21, 2025

Ilika plc has announced a proposed capital raising of approximately £3.5 million through a combination of a placing, retail offer, and director subscriptions. The funds will be used to advance the commercial status of its Stereax and Goliath product lines, supporting technology transfer, testing, and customer engagement. This move is expected to enhance Ilika’s market positioning by facilitating the commercial launch of its small format Stereax technology and the development of its large format Goliath technology, potentially leading to commercial licensing agreements.

The most recent analyst rating on (GB:IKA) stock is a Buy with a £97.00 price target. To see the full list of analyst forecasts on Ilika plc stock, see the GB:IKA Stock Forecast page.

Shareholder MeetingsBusiness Operations and Strategy
Ilika plc Announces 2025 Retail Investor Day
Neutral
May 7, 2025

Ilika plc announced it will host a Retail Investor Day on May 20, 2025, at its facilities in Southampton, UK. The event, led by the executive management team, will offer a strategic update on the business and tours of the Stereax manufacturing and Goliath development facilities. While no new material information on current trading will be disclosed, the event is an opportunity for stakeholders to gain insights into Ilika’s operations and future directions.

Product-Related AnnouncementsBusiness Operations and Strategy
Ilika plc Advances Goliath Battery Production with UKBIC Collaboration
Positive
Apr 15, 2025

Ilika plc has achieved a significant milestone in the development of its Goliath solid-state batteries, confirming superior performance and higher manufacturing yield through an industrial-scale process at the UK Battery Industrialisation Centre. This advancement supports the battery’s market readiness, promising reduced costs, increased range, and faster charging times for electric vehicles. The successful completion of Project SiSTEM, in collaboration with UKBIC and other partners, demonstrates the viability of large-scale production using existing gigafactory equipment, enhancing Ilika’s position in the automotive electrification sector.

Product-Related AnnouncementsBusiness Operations and Strategy
Ilika Achieves Milestone in Solid-State EV Battery Development
Positive
Mar 6, 2025

Ilika plc has achieved a significant milestone by successfully prototyping a 50Ah Goliath electric vehicle battery, marking a key outcome of the Faraday Battery Challenge HISTORY programme. This development is expected to enhance the cost efficiency, range, and charging time of electric vehicles. Following the prototype’s success, Ilika plans further optimization and testing, with a target to release the batteries for partner evaluation by the end of 2025. This progress aligns with the UK government’s funding initiative for transport electrification and highlights Ilika’s readiness for deeper engagement with automotive partners.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 04, 2025